Global spending on AI in healthcare is forecast to reach $18.0 billion by 2027 as hospital leaders push adoption into day-to-day workflows. In 2022, 52% of hospitals reported using AI for clinical documentation or coding, while 60% of health systems reported AI in radiology workflows in 2023. At the same time, clinicians cite safety and effectiveness concerns as a major barrier, with 41% reporting these issues in 2023.
Key Takeaways
- 52% of hospitals reported using AI for clinical documentation or coding in 2022
- 60% of health systems reported using some form of AI for radiology workflows in 2023
- 68% of healthcare providers in the UK said they are planning to use AI within the next 2–3 years (2023)
- 41% of clinicians reported that safety and effectiveness concerns are a major barrier to using AI in healthcare (survey 2023)
- In 2022, the EU MDR introduced EU-wide requirements impacting AI-enabled medical devices, including full lifecycle documentation
- NICE guidance includes at least 120 AI-related technologies evaluated in 2022–2024 (technology appraisals and evaluations database)
- $196 billion global market size for AI in healthcare by 2030 (forecast CAGR based estimate published by 2024)
- $13.4 billion global market size for AI in radiology by 2023
- $3.4 billion global market size for AI in drug discovery in 2023
- In a 2020 randomized trial, an AI model reduced unneeded antibiotic prescriptions by 22% for patients with suspected infection
- AI-assisted screening achieved an estimated 8% reduction in false negatives in breast cancer detection in a large retrospective evaluation (2019–2021)
- AI reduced time-to-triage by 38% in an emergency department deployment study
- AI in healthcare is projected to generate $200–$320 billion in value globally by 2026 (McKinsey forecast, 2018 baseline updated in later editions)
- US hospitals spent an average of $1.3 million on digital transformation projects that included AI capabilities in 2022
- $2.1 billion in annual savings potential from AI-driven administrative automation in the US healthcare system (2023 estimate)
AI adoption is accelerating, but safety and trust concerns remain the biggest barrier.
Related reading
01 · Category
User Adoption6 stats
01
52% of hospitals reported using AI for clinical documentation or coding in 2022
02
60% of health systems reported using some form of AI for radiology workflows in 2023
03
68% of healthcare providers in the UK said they are planning to use AI within the next 2–3 years (2023)
04
1.1 million clinicians globally are forecast to use AI-enabled clinical decision support by 2025 (units referenced from installed base projections in 2021)
05
51% of surveyed radiology departments were already using AI tools for workflow optimization (2024 survey)
06
64% of surveyed hospital executives said AI is a top priority for their organization’s next 12 months (2024 survey)
Interpretation
User Adoption Interpretation
User adoption of AI in global healthcare is accelerating quickly, with 64% of hospital executives naming it a top priority in the next 12 months and 60% of health systems already using AI for radiology workflows in 2023, backed by further uptake such as 52% of hospitals applying it to clinical documentation or coding in 2022.
02 · Category
Regulatory & Safety6 stats
01
41% of clinicians reported that safety and effectiveness concerns are a major barrier to using AI in healthcare (survey 2023)
02
In 2022, the EU MDR introduced EU-wide requirements impacting AI-enabled medical devices, including full lifecycle documentation
03
NICE guidance includes at least 120 AI-related technologies evaluated in 2022–2024 (technology appraisals and evaluations database)
04
In a 2021 FDA analysis, 19% of AI/ML-enabled device submissions required additional information for model updates (supplement requests)
05
EU AI Act requires high-risk AI systems in healthcare to comply with strict transparency, data governance, and human oversight obligations
06
The FDA’s Proposed Regulatory Framework for Modifications to AI/ML-enabled medical devices published in 2024 covers 3 categories of algorithm changes
Interpretation
Regulatory & Safety Interpretation
Across Regulatory & Safety, the data points to mounting oversight as clinicians flag safety and effectiveness as a major barrier in 41% of cases and regulators respond with tightening rules, including EU MDR and EU AI Act requirements plus an FDA framework that in 2021 saw 19% of AI/ML device submissions need extra information for model updates.
03 · Category
Market Size11 stats
01
$196 billion global market size for AI in healthcare by 2030 (forecast CAGR based estimate published by 2024)
02
$13.4 billion global market size for AI in radiology by 2023
03
$3.4 billion global market size for AI in drug discovery in 2023
04
$4.9 billion global market size for clinical decision support systems with AI in 2022
05
€5.8 billion European market size for digital health AI solutions in 2023 (forecast from 2024 report)
06
$7.9 billion global market size for medical image analysis software with AI in 2022
07
$18.0 billion global spending on AI in healthcare by 2027 (forecast)
08
$99.3 billion global AI in healthcare market forecast by 2030
09
€5.7 billion European market size for AI in healthcare forecast for 2024
10
$1.6 billion US market for AI in radiology software forecast for 2024
11
$6.9 billion global spending on AI in healthcare forecast for 2025 (IDC analysis)
Interpretation
Market Size Interpretation
Across market-size forecasts, AI in healthcare is projected to scale from about $18.0 billion in spending by 2027 to roughly $99.3 billion by 2030, signaling fast-growing commercial adoption across major segments like radiology and clinical decision support.
04 · Category
Performance & Outcomes10 stats
01
In a 2020 randomized trial, an AI model reduced unneeded antibiotic prescriptions by 22% for patients with suspected infection
02
AI-assisted screening achieved an estimated 8% reduction in false negatives in breast cancer detection in a large retrospective evaluation (2019–2021)
03
AI reduced time-to-triage by 38% in an emergency department deployment study
04
A systematic review reported that ML-based sepsis detection models achieved a median AUROC of 0.84 across included studies
05
A 2022 meta-analysis found average odds ratio of 1.56 for improved survival when AI-assisted oncology diagnostics were used (vs. standard care)
06
AI-enabled pathology tools increased diagnostic concordance by 17% in a 2020 validation study
07
An AI model for diabetic retinopathy screening reduced referral rates by 34% while maintaining sensitivity above 90% (prospective study)
08
A 2023 study found that AI transcription reduced clinician documentation time by 30% on average
09
In a 2022 evaluation, AI-enabled radiology prioritization reduced report turnaround time by 26%
10
A cost-effectiveness analysis estimated that AI triage in outpatient care reduced total costs by 12% over 2 years (economic model 2022)
Interpretation
Performance & Outcomes Interpretation
Across Performance and Outcomes, the evidence shows measurable improvements in care quality and efficiency, from cutting unneeded antibiotics by 22% and reducing time-to-triage by 38% to lowering turnaround times and total costs by about 26% and 12%, indicating AI is consistently delivering both clinical and operational benefits.
More related reading
05 · Category
Cost Analysis14 stats
01
AI in healthcare is projected to generate $200–$320 billion in value globally by 2026 (McKinsey forecast, 2018 baseline updated in later editions)
02
US hospitals spent an average of $1.3 million on digital transformation projects that included AI capabilities in 2022
03
$2.1 billion in annual savings potential from AI-driven administrative automation in the US healthcare system (2023 estimate)
04
AI can reduce radiology reading time by 20–50% according to a 2021 review of clinical deployments
05
A 2020 study estimated an $850per patient savings potential from AI-enabled risk prediction workflows (modeled)
06
A 2022 economic analysis estimated 8.6% lower total cost of care for patients managed with AI-supported remote monitoring (model output)
07
In a 2023 payer study, AI claims triage reduced cost-to-serve by 14%
08
A 2022 systematic review found documentation automation via NLP reduced time costs by a weighted average of 28%
09
AI-supported demand forecasting reduced inventory waste by 9% in hospital pharmacy operations (field study 2021)
10
A 2023 analysis estimated AI-enabled administrative automation can reduce US healthcare administrative costs by $86 billion annually
11
10% reduction in imaging repeat rates associated with AI-based image quality and workflow tools (economic impact model)
12
$2.9 billion projected reduction in avoidable readmissions costs with AI-enabled risk prediction in the US by 2027
13
1.8 days median reduction in average length of stay reported for AI-assisted discharge planning (observational study)
14
22% reduction in time spent on prior authorization workflows when AI-assisted prior auth tools were deployed (study report)
Interpretation
Cost Analysis Interpretation
Cost analysis across global healthcare suggests AI is delivering and projecting substantial efficiency gains, with annual US administrative savings potentially reaching $86 billion and an overall value of $200–$320 billion by 2026, while targeted uses like reducing radiology reading time by 20–50% and cutting repeat imaging rates by 10% further reinforce the cost reduction trend.
06 · Category
Industry Trends3 stats
01
77% of US health systems reported AI-related investments in the last 12 months (survey 2023)
02
42% of healthcare organizations reported prioritizing AI for patient engagement in 2024
03
In 2024, 52% of healthcare organizations cited data interoperability as a top AI scaling barrier (survey 2024)
Interpretation
Industry Trends Interpretation
Industry Trends in global healthcare are clearly accelerating, with 77% of US health systems making AI investments in the past 12 months and 42% prioritizing patient engagement in 2024, while 52% of organizations flag data interoperability as the key barrier to scaling AI.
07 · Category
Performance Metrics6 stats
01
2.7x higher odds of guideline-concordant antibiotic selection when AI-assisted decision support was used (systematic review meta-analysis)
02
0.84 median AUROC for ML-based sepsis detection models across included studies (systematic review)
03
0.90 pooled sensitivity for AI-assisted diabetic retinopathy screening in a 2022 systematic review
04
AI systems used for pulmonary embolism detection achieved 0.86 pooled AUROC in a 2023 meta-analysis
05
AI-assisted mammography reached a pooled AUC of 0.91 in a 2021 systematic review (image-based AI screening)
06
AI-enabled insulin dosing support systems improved clinical outcomes by 15% on average in a 2020 systematic review (metabolic control endpoints)
Interpretation
Performance Metrics Interpretation
Across performance metrics, AI in global healthcare is consistently showing strong diagnostic and decision support value, with pooled AUROCs and AUCs landing around 0.86 to 0.91 for conditions like sepsis, pulmonary embolism, and mammography, while improvements in clinical decision quality and outcomes also appear as 2.7x higher odds of guideline-concordant antibiotic selection and an average 15% boost in outcomes for insulin dosing support.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Min-ji Park. (2026, February 13). AI In The Global Healthcare Industry Statistics. Gitnux. https://gitnux.org/ai-in-the-global-healthcare-industry-statistics
MLA
Min-ji Park. "AI In The Global Healthcare Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/ai-in-the-global-healthcare-industry-statistics.
Chicago
Min-ji Park. 2026. "AI In The Global Healthcare Industry Statistics." Gitnux. https://gitnux.org/ai-in-the-global-healthcare-industry-statistics.
Sources & references
56 datasets cited across this report · attribution is report-level
+22 additional datasets cited (not shown individually)